BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37884346)

  • 1. Using qualitative free-text data to investigate the lived experience of the COVID-19 pandemic for a large cohort of Australians with different multiple sclerosis related disability levels.
    Campbell JA; van der Mei I; Taylor BV; Palmer AJ; Henson GJ; Laslett LL; Simpson-Yap S; Claflin SB
    J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):975-983. PubMed ID: 37884346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 Pandemic on the Personal Networks and Neurological Outcomes of People With Multiple Sclerosis: Cross-Sectional and Longitudinal Case-Control Study.
    Riley C; Venkatesh S; Dhand A; Doshi N; Kavak K; Levit E; Perrone C; Weinstock-Guttman B; Longbrake E; De Jager P; Xia Z
    JMIR Public Health Surveill; 2024 Feb; 10():e45429. PubMed ID: 38319703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological impacts of COVID-19 pandemic on individuals living with multiple sclerosis: A rapid systematic review.
    Zarghami A; Hussain MA; Campbell JA; Ezegbe C; van der Mei I; Taylor BV; Claflin SB
    Mult Scler Relat Disord; 2022 Mar; 59():103562. PubMed ID: 35149393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quality of life impact of the COVID-19 pandemic and lockdowns for people living with multiple sclerosis (MS): evidence from the Australian MS Longitudinal Study.
    Henson GJ; van der Mei I; Taylor BV; Blacklow P; Claflin SB; Palmer AJ; Hurst C; Campbell JA
    Qual Life Res; 2024 Jun; 33(6):1675-1689. PubMed ID: 38578380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: A combined survey and insurance claims study.
    Meltzer E; Charron O; Wozny J; Onuorah H; Montague A; Kline AC; Largent A; Krause TM; Freeman L
    Mult Scler Relat Disord; 2023 Dec; 80():105085. PubMed ID: 37931487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies.
    Beesley R; Cauchi M; Davies L; Upcott M; Norton E; Loveless S; Anderson V; Wynford-Thomas R; Pickersgill TP; Uzochukwu E; Wardle M; Robertson NP; Tallantyre E; Willis MD
    Mult Scler Relat Disord; 2022 Dec; 68():104121. PubMed ID: 36088727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and characteristics of falls in people living with and without multiple sclerosis during the COVID-19 pandemic: A cross-sectional online survey.
    Zanotto T; Frechette ML; Koziel SR; Hsieh KL; Sosnoff JJ
    Mult Scler Relat Disord; 2021 Sep; 54():103111. PubMed ID: 34303279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic health record data for assessing risk of hospitalization for COVID-19: Methodological considerations applied to multiple sclerosis.
    Dillon P; Siadimas A; Roumpanis S; Fajardo O; Fitovski K; Jessop N; Whitley L; Muros-Le Rouzic E
    Mult Scler Relat Disord; 2023 Mar; 71():104512. PubMed ID: 36716576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A year with the fear of COVID-19 in multiple sclerosis patients: Examination of depression, sleep quality and quality of life before and after the pandemic.
    Yeni K; Tulek Z; Terzi M
    Mult Scler Relat Disord; 2022 Jan; 57():103370. PubMed ID: 35158434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing communication changes in persons with multiple sclerosis: Findings from qualitative focus groups.
    El-Wahsh S; Balandin S; Bogaardt H; Kumfor F; Ballard KJ
    Int J Lang Commun Disord; 2022 May; 57(3):680-694. PubMed ID: 35338749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the working life of people with multiple sclerosis during the COVID-19 pandemic in Sweden.
    Murley C; Dervish J; Machado A; Svärd V; Wennman-Larsen A; Hillert J; Friberg E
    BMC Public Health; 2024 May; 24(1):1389. PubMed ID: 38783221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey.
    Altieri M; Capuano R; Bisecco A; d'Ambrosio A; Risi M; Cavalla P; Vercellino M; Annovazzi P; Zaffaroni M; De Stefano N; Stromillo ML; D'Amico E; Zanghì A; Buscarinu MC; Lanzillo R; De Luca G; Calabrese M; Lorefice L; Di Filippo M; Valentino P; Gajofatto A; Marfia GA; Fuiani A; Nociti V; Tedeschi G; Gallo A
    Mult Scler Relat Disord; 2023 Sep; 77():104870. PubMed ID: 37454568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived stress and social support in a large population of people with multiple sclerosis recruited online through the COVID-19 pandemic.
    Bonavita S; Sparaco M; Russo A; Borriello G; Lavorgna L
    Eur J Neurol; 2021 Oct; 28(10):3396-3402. PubMed ID: 33368849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis.
    Altieri M; Capuano R; Bisecco A; d'Ambrosio A; Buonanno D; Tedeschi G; Santangelo G; Gallo A
    Mult Scler Relat Disord; 2022 May; 61():103774. PubMed ID: 35381533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The psychological impact of the COVID-19 pandemic on people with multiple sclerosis.
    Vacaras V; Nistor C; Schiopu AM; Vacaras C; Marin GE; Muresanu DF
    Mult Scler Relat Disord; 2023 Aug; 76():104825. PubMed ID: 37320938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social support predicts sleep quality in people with multiple sclerosis during the COVID-19 pandemic.
    Harris TP; Zaeske LM; Ludwig R; Baker S; Lynch S; Thuringer A; Bruce J; Siengsukon CF
    Mult Scler Relat Disord; 2022 Aug; 64():103970. PubMed ID: 35728433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Telemedicine Among People with Multiple Sclerosis Before and During the COVID-19 Pandemic.
    Sumner L; Schmidt H; Minden S; Falkenberg N; Sun L; McBurney R; Loud S; Wallin M
    Telemed J E Health; 2023 Aug; 29(8):1152-1163. PubMed ID: 36493358
    [No Abstract]   [Full Text] [Related]  

  • 18. Physical Activity in Multiple Sclerosis: Meeting the Guidelines at the Time of the COVID-19 Pandemic.
    Pedullà L; Santoyo-Medina C; Novotna K; Moumdjian L; Smedal T; Arntzen EC; van der Linden ML; Learmonth Y; Kalron A; Güngör F; Nedeljkovic U; Kos D; Jonsdottir J; Coote S; Tacchino A
    J Neurol Phys Ther; 2023 Apr; 47(2):112-121. PubMed ID: 36753458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fear of COVID-19, problems accessing medical appointments, and subjective experience of disease progression, predict anxiety and depression reactions in patients with Multiple Sclerosis.
    Broche-Pérez Y; Jiménez-Morales RM; Monasterio-Ramos LO; Vázquez-Gómez LA; Fernández-Fleites Z
    Mult Scler Relat Disord; 2021 Aug; 53():103070. PubMed ID: 34119745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of COVID-19 pandemic lockdown on the physical activity of people with multiple sclerosis. The role of online training.
    Matysiak M; Siger M; Walczak A; Ciach A; Jonakowski M; Stasiołek M
    Mult Scler Relat Disord; 2022 Jul; 63():103843. PubMed ID: 35550480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.